Apiam Animal Health (ASX:AHX) Cash Conversion Cycle: 52.49 (As of Jun. 2025)


ASX:AHX Apiam Animal Health Ltd ASX:AHX
50 GF Score
Price A$0.88
GF Value A$0.40
! 9 Warning Signs
View Full Analysis

What is Apiam Animal Health Cash Conversion Cycle?

Apiam Animal Health ASX:AHX 50 Cash Conversion Cycle is 52.49 as of Jun. 2025. GuruFocus rates ASX:AHX with a GF Score™ of 50/100 and a GF Value™ of A$0.40. The stock has 9 warning signs investors should review.

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Apiam Animal Health's Days Sales Outstanding for the six months ended in Jun. 2025 was 25.14.
Apiam Animal Health's Days Inventory for the six months ended in Jun. 2025 was 82.16.
Apiam Animal Health's Days Payable for the six months ended in Jun. 2025 was 54.81.
Therefore, Apiam Animal Health's Cash Conversion Cycle (CCC) for the six months ended in Jun. 2025 was 52.49.


Apiam Animal Health  (ASX:AHX) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Apiam Animal Health Cash Conversion Cycle Related Terms


Apiam Animal Health Cash Conversion Cycle Historical Data

* Premium members only.

The historical data trend for Apiam Animal Health's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apiam Animal Health Cash Conversion Cycle Chart

Apiam Animal Health Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only 107.35 95.42 80.40 72.90 72.46

Apiam Animal Health Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63.34 54.58 54.63 48.99 52.49

ASX:AHX vs ROL, SCI, BFAM: Cash Conversion Cycle Comparison

For the Personal Services subindustry, Apiam Animal Health's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Apiam Animal Health Cash Conversion Cycle vs Personal Services Industry

For the Personal Services industry and Consumer Cyclical sector, Apiam Animal Health's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Apiam Animal Health's Cash Conversion Cycle falls into.


ASX:AHX
50GF Score
Apiam Animal Health Ltd ASX:AHX
Cash Conversion Cycle is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apiam Animal Health Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Apiam Animal Health's Cash Conversion Cycle for the fiscal year that ended in Jun. 2025 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=22.45+79.82-29.81
=72.46

Apiam Animal Health's Cash Conversion Cycle for the quarter that ended in Jun. 2025 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=25.14+82.16-54.81
=52.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash Conversion Cycle →
What does a Cash Conversion Cycle of 52.49 mean?
Apiam Animal Health (ASX:AHX) has a Cash Conversion Cycle of 52.49 as of Jun. 2025. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Apiam Animal Health and its competitors.
Is Apiam Animal Health's Cash Conversion Cycle too high?
Apiam Animal Health's current Cash Conversion Cycle is 52.49. The Personal Services industry median Cash Conversion Cycle is 20.66. Apiam Animal Health's value of 52.49 is 154.1% above this industry median. Overall, Apiam Animal Health has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Apiam Animal Health's Cash Conversion Cycle compare to ROL and SCI?
Apiam Animal Health's Cash Conversion Cycle of 52.49 can be compared against companies in the Personal Services industry. The industry median Cash Conversion Cycle is 20.66. Apiam Animal Health's value of 52.49 is 154.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Personal Services company?
The median Cash Conversion Cycle among Personal Services companies is 20.66, based on 97 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apiam Animal Health's current Cash Conversion Cycle of 52.49 is 154.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Apiam Animal Health and its competitors. For the Personal Services industry, the median Cash Conversion Cycle is 20.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apiam Animal Health's current Cash Conversion Cycle is 52.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apiam Animal Health stock overvalued right now?
Apiam Animal Health (ASX:AHX) has a current Cash Conversion Cycle of 52.49. The stock's GF Value™ is A$0.40, compared to a current price of A$0.88 — trading 118.8% above its estimated fair value. The current Cash Conversion Cycle is 52.49 and 154.1% above the Personal Services industry median of 20.66. Apiam Animal Health's overall GF Score™ is 50/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Apiam Animal Health (ASX:AHX), the current Cash Conversion Cycle is 52.49 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Apiam Animal Health (ASX:AHX) Overvalued in 2026?

Based on GuruFocus' analysis, Apiam Animal Health stock appears to be overvalued. The current stock price of A$0.88 is trading 118.8% above its estimated GF Value™ of A$0.40.

Key valuation signals for ASX:AHX:

  • Cash Conversion Cycle: 52.49
  • GF Value™: A$0.40 vs. price of A$0.88 (118.8% above fair value)
  • GF Score™: 50/100 with 9 warning signs
  • Industry Position: 154.1% above the Personal Services median

No single metric tells the full story. See the ASX:AHX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Apiam Animal Health Business Description

Address 27- 33 Piper Lane, East Bendigo, Bendigo, VIC, AUS, 3550
Apiam Animal Health Ltd provides products and services to support the health and welfare of production and mixed animals. The company offers veterinary wholesale, warehousing, logistics, and other ancillary services. Its operating segments include Dairy and Mixed, Feedlots and Pigs. It generates the majority of its revenue from Dairy and Mixed. The Group operates in the segment of provision of veterinary products and services to production, companion and equine animals.
50GF Score

Get the complete analysis for ASX:AHX

Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.88
Price
A$0.40
GF Value